Autopsy report · NCT01276054
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.
Cause of deathOther
“P.I. left”
Life of this trial
- Ran for about 10 months before it stopped.
- 4 participants enrolled.
- Results were posted on the registry 2 years 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of Southern California
- Sponsor type
- University, hospital or other
- Conditions
- Lymphedema; Recurrent Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer
- Interventions
- technetium Tc 99m sulfur colloid; methylene blue; indocyanine green solution; sentinel lymph node biopsy; axillary lymph node biopsy; bioimpedance spectroscopy
- Participants
- 4
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.